Am J Perinatol
DOI: 10.1055/a-2578-1875
Original Article

Neuroprotective Effects of Quercetin in Neonatal Hypoxic-Ischemic Brain Injury: A Meta-analysis

Authors

  • Ceren Can

    1   Department of Pediatric Allergy and Immunology, University of Health Sciences, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Türkiye
  • Şahin Hamilçıkan

    2   Department of Neonatology, University of Health Sciences, Bağcılar Training and Research Hospital, Istanbul, Türkiye

Funding None.
Preview

Abstract

Objective

This study assesses the neuroprotective potential of quercetin in preclinical models of neonatal hypoxic-ischemic brain injury (HIBI) and its role as a possible enhancer of therapeutic hypothermia.

Study Design

A systematic review of 8 preclinical studies was conducted per PRISMA guidelines, sourced from PubMed, Scopus, and Web of Science, with a random-effects meta-analysis.

Results

Quercetin significantly lowered infarct volume, seizure susceptibility, and inflammation (pooled standardized mean differences [SMD] = 1.29; 95% confidence interval [CI]: 1.00–1.58; p < 0.001). Higher doses (>30 mg/kg, SMD = 1.65) and intraperitoneal (IP) administration (SMD = 1.42) outperformed lower doses or intravenous (IV) routes (SMD = 0.95). Rat models showed greater benefits (SMD = 1.38) than piglets (SMD = 0.85). Moderate heterogeneity (I 2 = 45%) was noted, but sensitivity analysis confirmed robustness (SMD = 1.20). Publication bias was minimal (p = 0.12).

Conclusion

Quercetin offers notable neuroprotection in neonatal HIBI, with an optimal 40 mg/kg IP dose, suggesting it could complement hypothermia. Limited bioavailability and lack of long-term data call for further research in advanced models.

Key Points

  • Quercetin improves outcomes in neonatal HIBI.

  • IP route shows greater efficacy.

  • Higher doses (>30 mg/kg) are more effective.

  • Meta-analysis confirms significant benefit (SMD = 1.29).

  • Bioavailability remains a key translational barrier.



Publication History

Received: 21 February 2025

Accepted: 08 April 2025

Article published online:
30 April 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA